TXG 10x Genomics, Inc.
Healthcare$24.76+0.00%OpenMarket Cap: $3.14B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$22.43
Target (Median)
$22.00
Target Range
$17.00 - $30.00
Upside from current price: -9.4%
Rating Distribution
1 Strong Buy5 Buy10 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | JP Morgan | maintain | Neutral | Neutral |
| 2026-05-12 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-04-20 | B of A Securities | maintain | Neutral | Neutral |
| 2026-04-20 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-04-14 | Barclays | maintain | Overweight | Overweight |
| 2026-04-07 | Citigroup | maintain | Neutral | Neutral |
| 2026-03-31 | William Blair | upgrade | Outperform | Market Perform |
| 2026-03-02 | Stifel | maintain | Buy | Buy |
| 2026-02-20 | UBS | maintain | Neutral | Neutral |
| 2026-02-13 | TD Cowen | maintain | Hold | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.65 | $667.4M | 8 |
| Sun Dec 31 | $-0.45 | $722.2M | 11 |
| Mon Dec 31 | $-0.31 | $807.4M | 4 |
| Tue Dec 31 | $-0.08 | $904.7M | 4 |